Cite
HARVARD Citation
Oh, D. et al. (n.d.). 126OOlaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial. Annals of oncology. p. . [Online].